BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 95 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,868 | +72058.0% | 33,940 | +89.5% | 0.01% | -28.6% |
| Q2 2023 | $119 | -83.2% | 17,908 | -52.7% | 0.01% | -83.7% |
| Q1 2023 | $707 | -16.0% | 37,887 | -3.3% | 0.04% | -17.3% |
| Q4 2022 | $842 | -99.8% | 39,185 | +14.5% | 0.05% | +92.6% |
| Q3 2022 | $405,000 | -11.6% | 34,231 | -1.4% | 0.03% | -3.6% |
| Q2 2022 | $458,000 | -37.8% | 34,705 | -1.5% | 0.03% | -28.2% |
| Q1 2022 | $736,000 | +5.0% | 35,221 | +2.1% | 0.04% | +14.7% |
| Q4 2021 | $701,000 | -28.6% | 34,502 | +6.7% | 0.03% | -34.6% |
| Q3 2021 | $982,000 | +58.9% | 32,344 | +52.1% | 0.05% | +57.6% |
| Q2 2021 | $618,000 | – | 21,270 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 40,000 | $836,000 | 1.01% |
| ACT CAPITAL MANAGEMENT, LLC | 20,000 | $418,000 | 0.44% |
| Knoll Capital Management, LLC | 20,000 | $418,000 | 0.26% |
| Artemis Investment Management LLP | 1,428,228 | $29,855,000 | 0.24% |
| Rubric Capital Management LP | 268,528 | $5,615,000 | 0.20% |
| Virtus ETF Advisers LLC | 7,713 | $161,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 107,700 | $2,252,000 | 0.05% |
| PDT Partners, LLC | 28,031 | $586,000 | 0.05% |
| AllSquare Wealth Management LLC | 3,162 | $66,000 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 35,221 | $736,000 | 0.04% |